Oscar Health reports Q2 EPS 20c, consensus 16c

Reports Q2 revenue $2.22B, consensus $2.15B. “Oscar reported strong Q2 results, closing out the best six months in the company’s history,” said Mark Bertolini, CEO of Oscar Health. “We continued to report robust revenue growth, improved operating margin, and strong bottom line performance. Based on our outperformance in the first half of the year, we updated our FY24 guidance. We are well-positioned to deliver on our target for Adjusted EBITDA profitability this year.”